Butein Induces Apoptosis in Human Uveal Melanoma Cells Through Mitochondrial Apoptosis Pathway

REFERENCES

• Hu DN, Yu GP, McCormick SA, Schneider S, Finger PT. Population-based incidence of uveal melanoma in various races and ethnic groups. Am J Ophthalmol 2005;140:612–617.
   PubMed Web of Science ®Google Scholar
• Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003;44:4651–4659.
   PubMed Web of Science ®Google Scholar
• Jager MJ, Niederkorn JY, Ksander BR. Uveal melanoma. London: Taylor & Francis; 2004.
   Google Scholar
• Augsburger JJ, Corrêa ZM, Shaikh AH. Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol 2009;148:119–127.
   PubMed Web of Science ®Google Scholar
• Yadav VR, Prasad S, Sung B, Aggarwal BB. The role of chalcones in suppression of NF-kappaB-mediated inflammation and cancer. Int Immunopharmacol 2011;11:295–309.
   PubMed Web of Science ®Google Scholar
• Lee SH, Choi WC, Kim KS, Park JW, Lee SH, Yoon SW. Shrinkage of gastric cancer in an elderly patient who received Rhus verniciflua Stokes extract. J Altern Complement Med 2010;16:497–500.
   PubMed Web of Science ®Google Scholar
• Moon DO, Choi YH, Moon SK, Kim WJ, Kim GY. Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells. Toxicol In Vitro 2010;24:1927–1934.
   PubMed Web of Science ®Google Scholar
• Rasheed Z, Akhtar N, Khan A, Khan KA, Haqqi TM. Butrin, isobutrin, and butein from medicinal plant Butea monosperma selectively inhibit nuclear factor-kappaB in activated human mast cells: suppression of tumor necrosis factor-alpha, interleukin (IL)-6, and IL-8. J Pharmacol Exp Ther 2010;333:354–363.
   PubMed Web of Science ®Google Scholar
• Lee SH, Seo GS, Sohn DH. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by butein in RAW 264.7 cells. Biochem Biophys Res Commun 2004;323:125–132.
   PubMed Web of Science ®Google Scholar
• Lee JC, Lim KT, Jang YS. Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties. Biochim Biophys Acta 2002;1570:181–191.
   PubMed Web of Science ®Google Scholar
• Chan SC, Chang YS, Wang JP, Chen SC, Kuo SC. Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera. Planta Med 1998;64:153–158.
   PubMed Web of Science ®Google Scholar
• Rajendran P, Ong TH, Chen L, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, Hui KM, Sethi G. Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo. Clin Cancer Res 2011;17:1425–1439.
   PubMed Web of Science ®Google Scholar
• Lau GT, Huang H, Lin SM, Leung LK. Butein downregulates phorbol 12-myristate 13-acetate-induced COX-2 transcriptional activity in cancerous and non-cancerous breast cells. Eur J Pharmacol 2010;648:24–30.
   PubMed Web of Science ®Google Scholar
• Chua AW, Hay HS, Rajendran P, Shanmugam MK, Li F, Bist P, Koay ES, Lim LH, Kumar AP, Sethi G. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-kappaB activation in breast and pancreatic tumor cells. Biochem Pharmacol 2010;80:1553–1562.
   PubMed Web of Science ®Google Scholar
• Moon DO, Kim MO, Choi YH, Kim GY. Butein sensitizes human hepatoma cells to TRAIL-induced apoptosis via extracellular signal-regulated kinase/Sp1-dependent DR5 upregulation and NF-kappaB inactivation. Mol Cancer Ther 2010;9:1583–1595.
   PubMed Web of Science ®Google Scholar
• Szliszka E, Czuba ZP, Mazur B, Sedek L, Paradysz A, Krol W. Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells. Int J Mol Sci 2009;11:1–13.
   PubMed Web of Science ®Google Scholar
• Moon DO, Kim MO, Choi YH, Hyun JW, Chang WY, Kim GY. Butein induces G(2)/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation. Cancer Lett 2010;288:204–213.
   PubMed Web of Science ®Google Scholar
• Moon DO, Kim MO, Lee JD, Choi YH, Kim GY. Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells. Cancer Lett 2009;286:172–179.
   PubMed Web of Science ®Google Scholar
• Pandey MK, Sung B, Ahn KS, Aggarwal BB. Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Mol Pharmacol 2009;75:525–533.
   PubMed Web of Science ®Google Scholar
• Kim N. Butein sensitizes human leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis inducing ligand (TRAIL). Arch Pharm Res 2008;31:1179–1186.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen W, Li X. A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF-kappa B signaling pathways in bladder cancer cells. FEBS Lett 2008;582:1821–1828.
   PubMed Web of Science ®Google Scholar
• Pandey MK, Sandur SK, Sung B, Sethi G, Kunnumakkara AB, Aggarwal BB. Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue. J Biol Chem 2007;282:17340–17350.
   PubMed Web of Science ®Google Scholar
• Jang HS, Kook SH, Son YO, Kim JG, Jeon YM, Jang YS, Choi KC, Kim J, Han SK, Lee KY, Park BK, Cho NP, Lee JC.. Flavonoids purified from Rhus verniciflua Stokes actively inhibit cell growth and induce apoptosis in human osteosarcoma cells. Biochim Biophys Acta 2005;1726:309–316.
   PubMed Web of Science ®Google Scholar
• Samoszuk M, Tan J, Chorn G. The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts. BMC Complement Altern Med 2005;5:5.
   PubMedGoogle Scholar
• Lee JC, Lee KY, Kim J, Na CS, Jung NC, Chung GH, Jang YS. Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells. Food Chem Toxicol 2004;42:1383–1388.
   PubMed Web of Science ®Google Scholar
• Iwashita K, Kobori M, Yamaki K, Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci Biotechnol Biochem 2000;64:1813–1820.
   PubMed Web of Science ®Google Scholar
• Yit CC, Das NP. Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Lett 1994;82:65–72.
   PubMed Web of Science ®Google Scholar
• Ramanathan R, Tan CH, Das NP. Cytotoxic effect of plant polyphenols and fat-soluble vitamins on malignant human cultured cells. Cancer Lett 1992;62:217–224.
   PubMed Web of Science ®Google Scholar
• Kim NY, Pae HO, Oh GS, Kang TH, Kim YC, Rhew HY, Chung HT. Butein, a plant polyphenol, induces apoptosis concomitant with increased caspase-3 activity, decreased Bcl-2 expression and increased Bax expression in HL-60 cells. Pharmacol Toxicol 2001;88:261–266.
   PubMedGoogle Scholar
• Zhang K, Wong KP. Inhibition of the efflux of glutathione S-conjugates by plant polyphenols. Biochem Pharmacol 1996;52:1631–1638.
   PubMed Web of Science ®Google Scholar
• Opletalová V, Jahodár L, Jun D, Opletal L. Chalcones (1,3-diarylpropen-1-ones) and their analogs as potential therapeutic agents in cardiovascular system diseases. Ceska Slov Farm 2003;52:12–19.
   PubMedGoogle Scholar
• Kang DG, Lee AS, Mun YJ, Woo WH, Kim YC, Sohn EJ, Moon MK, Lee HS. Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biol Pharm Bull 2004;27:366–370.
   PubMed Web of Science ®Google Scholar
• Hu DN, McCormick SA. Progress in the studies of etiology, epidemiology and pathogenesis of ocular melanomas. Yan Ke Xue Bao 2011;26:18–22.
   Google Scholar
• Hu DN, Simon JD, Sarna T. Role of ocular melanin in ophthalmic physiology and pathology. Photochem Photobiol 2008;84:639–644.
   PubMed Web of Science ®Google Scholar
• Yu GP, Hu DN, McCormick SA. Latitude and incidence of ocular melanoma. Photochem Photobiol 2006;82:1621–1626.
   PubMed Web of Science ®Google Scholar
• Bergman L, Seregard S, Nilsson B, Ringborg U, Lundell G, Ragnarsson-Olding B. Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci 2002;43:2579–2583.
   PubMed Web of Science ®Google Scholar
• Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O’Brien J, Bastian BC. Mutations in GNA11 in uveal melanoma. N Engl J Med 2010;363:2191–2199.
   PubMed Web of Science ®Google Scholar
• Vajdic CM, Hutchins AM, Kricker A, Aitken JF, Armstrong BK, Hayward NK, Armes JE. Chromosomal gains and losses in ocular melanoma detected by comparative genomic hybridization in an Australian population-based study. Cancer Genet Cytogenet 2003;144:12–17.
   PubMed Web of Science ®Google Scholar
• Hu DN, McCormick SA. Biochemical pathways: Different gene expression and cellular pathways determining tumor phenotype comparision of uveal melanocytes and uveal melanoma cells in vitro. In: Albert DM, Polans A, eds.Ocular Oncology. New York, NY: Marcel Dekker; 2003;189–210.
   Google Scholar
• Soulieres D, Rousseau A, Deschenes J, Tremblay M, Tardif M, Pelletier G. Characterization of gangliosides in human uveal melanoma cells. Int J Cancer 1991;49:498–503.
   PubMed Web of Science ®Google Scholar
• Daniels KJ, Boldt HC, Martin JA, Gardner LM, Meyer M, Folberg R. Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression. Lab Invest 1996;75:55–66.
   PubMed Web of Science ®Google Scholar
• Lu C, Song E, Hu DN, Chen M, Xue C, Rosen R, McCormick SA. Curcumin induces cell death in human uveal melanoma cells through mitochondrial pathway. Curr Eye Res 2010;35:352–360.
   PubMed Web of Science ®Google Scholar
• Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 1993;197:40–45.
   PubMed Web of Science ®Google Scholar
• Batovska DI, Todorova IT. Trends in utilization of the pharmacological potential of chalcones. Curr Clin Pharmacol 2010;5:1–29.
   PubMedGoogle Scholar
• Herencia F, Ferrándiz ML, Ubeda A, Guillén I, Dominguez JN, Charris JE, Lobo GM, Alcaraz MJ. Novel anti-inflammatory chalcone derivatives inhibit the induction of nitric oxide synthase and cyclooxygenase-2 in mouse peritoneal macrophages. FEBS Lett 1999;453:129–134.
   PubMed Web of Science ®Google Scholar
• Vogel S, Barbic M, Jürgenliemk G, Heilmann J. Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect. Eur J Med Chem 2010;45:2206–2213.
   PubMed Web of Science ®Google Scholar
• Han H, Zhao Y, Cuthbertson T, Hartman RF, Rose SD. Cell cycle arrest and apoptosis induction by an anticancer chalcone epoxide. Arch Pharm (Weinheim) 2010;343:429–439.
   PubMed Web of Science ®Google Scholar
• Roberts JE, Wiechmann AF, Hu DN. Melatonin receptors in human uveal melanocytes and melanoma cells. J Pineal Res 2000;28:165–171.
   PubMed Web of Science ®Google Scholar
• Tardif M, Coulombe J, Soulières D, Rousseau AP, Pelletier G. Gangliosides in human uveal melanoma metastatic process. Int J Cancer 1996;68:97–101.
   PubMed Web of Science ®Google Scholar
• Lu F, Yan D, Zhou X, Hu DN, Qu J. Expression of melanin-related genes in cultured adult human retinal pigment epithelium and uveal melanoma cells. Mol Vis 2007;13:2066–2072.
   PubMed Web of Science ®Google Scholar
• Yan D, Zhou X, Chen X, Hu DN, Dong XD, Wang J, Lu F, Tu L, Qu J. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci 2009;50:1559–1565.
   PubMed Web of Science ®Google Scholar
• Braun RD, Abbas A. Orthotopic human choroidal melanoma xenografts in nude rats with aggressive and nonaggressive PAS staining patterns. Invest Ophthalmol Vis Sci 2006;47:7–16.
   PubMed Web of Science ®Google Scholar
• van Engeland M, Ramaekers FC, Schutte B, Reutelingsperger CP. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 1996;24:131–139.
   PubMedGoogle Scholar
• Mayer B, Oberbauer R. Mitochondrial regulation of apoptosis. News Physiol Sci 2003;18:89–94.
   PubMedGoogle Scholar
• Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 1998;60:619–642.
   PubMed Web of Science ®Google Scholar
• McConkey DJ. Biochemical determinants of apoptosis and necrosis. Toxicol Lett 1998;99:157–168.
   PubMed Web of Science ®Google Scholar
• Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 1996;184:1155–1160.
   PubMed Web of Science ®Google Scholar